547.47
+3.45
+(0.63%)
At close: January 10 at 4:00:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 21 | 27 | 27 |
| Avg. Estimate | 1.75 | 1.78 | 6.87 | 7.86 |
| Low Estimate | 1.61 | 1.71 | 6.42 | 7.24 |
| High Estimate | 1.92 | 1.83 | 7.11 | 8.38 |
| Year Ago EPS | 1.6 | 1.5 | 5.71 | 6.87 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 23 | 17 | 31 | 31 |
| Avg. Estimate | 2.2B | 2.2B | 8.14B | 9.52B |
| Low Estimate | 2.14B | 2.16B | 8.01B | 9.3B |
| High Estimate | 2.25B | 2.25B | 8.2B | 9.78B |
| Year Ago Sales | 1.93B | 1.89B | 7.12B | 8.14B |
| Sales Growth (year/est) | 14.33% | 16.53% | 14.28% | 16.89% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 1.49 | 1.42 | 1.54 | 1.64 |
| EPS Actual | 1.6 | 1.5 | 1.78 | 1.84 |
| Difference | 0.11 | 0.08 | 0.24 | 0.2 |
| Surprise % | 7.72% | 5.98% | 15.51% | 12.25% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.75 | 1.78 | 6.87 | 7.86 |
| 7 Days Ago | 1.75 | 1.78 | 6.86 | 7.85 |
| 30 Days Ago | 1.75 | 1.78 | 6.84 | 7.83 |
| 60 Days Ago | 1.75 | 1.78 | 6.89 | 7.83 |
| 90 Days Ago | 1.71 | 1.76 | 6.66 | 7.69 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 2 | 1 |
| Up Last 30 Days | 4 | -- | 2 | 4 |
| Down Last 7 Days | -- | 1 | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ISRG | 9.58% | 18.40% | 20.25% | 14.40% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 12/18/2024 |
| Maintains | Citigroup: Buy to Buy | 12/11/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 12/11/2024 |
| Maintains | Stifel: Buy to Buy | 12/5/2024 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 12/2/2024 |
| Maintains | BTIG: Buy to Buy | 11/26/2024 |
Related Tickers
MBOT Microbot Medical Inc.
1.9300
+3.21%
ALGN Align Technology, Inc.
212.12
-1.51%
BDX Becton, Dickinson and Company
233.67
-0.32%
RMD ResMed Inc.
233.82
-1.00%
BNGO Bionano Genomics, Inc.
0.2266
-0.31%
POAI Predictive Oncology Inc.
1.3600
+1.49%
ANGO AngioDynamics, Inc.
12.30
-4.95%
HOLX Hologic, Inc.
71.70
-1.43%
WRBY Warby Parker Inc.
25.32
-4.85%
BAX Baxter International Inc.
29.42
-0.57%